Skip to main content
Top
Published in: Pathology & Oncology Research 4/2015

01-09-2015 | Research

Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program

Authors: Mariann Moizs, Gábor Bajzik, Zsuzsanna Lelovics, János Strausz, Marianna Rakvács, Péter Zádori, Árpád Kovács, Imre Repa

Published in: Pathology & Oncology Research | Issue 4/2015

Login to get access

Abstract

In the past years the participation rate in conventional voluntary x-ray lung screening has been around 22 % in Somogy County in Hungary. Due to the high morbidity and mortality rates of lung cancer, low participation rate of the high risk individuals on the screening is a primary question in Hungary. To obtain an effectively high level of participation in our ongoing low dose CT screening program, we had to emphasize the benefits of participation for the targeted individuals. As a first step, our aim was to gather information on the aspects affecting the individuals’ will for participation. We used the most accessible source of information: individuals over the age of 50, who attended the conventional voluntary lung screening, were approached to fill a questionnaire on their habits relating to smoking, health issues and their prior participation of lung screening. 1080 adults anonymously completed the questionnaire. Analyzing the results, beside other findings, we found a unique variable factor, which altered negatively the compliance for the screening: older individuals, who started participating in the screening in obligation to the health regulations, took part in the voluntary screening programs at a significantly lower rate. Our findings led us to better understanding the complexity of decision making affecting the individual’s participation and attitudes toward health issues. Trial registration: IG/03833/2012.
Literature
1.
go back to reference NCCN (2012) National Comprehensive Cancer Network: Lung Cancer Screening Guidelines. Ver. 1 NCCN (2012) National Comprehensive Cancer Network: Lung Cancer Screening Guidelines. Ver. 1
4.
go back to reference La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F (2010) Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 21:1323–1360CrossRefPubMed La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F (2010) Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 21:1323–1360CrossRefPubMed
5.
go back to reference Ostoros G (2013) Lung cancer. Korányi Bull 1:24–31, In Hung Ostoros G (2013) Lung cancer. Korányi Bull 1:24–31, In Hung
6.
go back to reference Kovács G (2008) The 50 years of the chest X-ray screeing in Hungary. Med Thorac 61:76–89, In Hung Kovács G (2008) The 50 years of the chest X-ray screeing in Hungary. Med Thorac 61:76–89, In Hung
8.
go back to reference Rampinelli C, Preda L, Maniglio M, Sirica L, Travaini LL, Veronesi G, Bellomi M (2011) Extrapulmonary malignancies detected at lung cancer screening. Radiology 261:293–299CrossRefPubMed Rampinelli C, Preda L, Maniglio M, Sirica L, Travaini LL, Veronesi G, Bellomi M (2011) Extrapulmonary malignancies detected at lung cancer screening. Radiology 261:293–299CrossRefPubMed
9.
go back to reference Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C (2012) Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21:308–315CrossRefPubMed Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C (2012) Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21:308–315CrossRefPubMed
10.
go back to reference Moizs M, Bajzik G, Lelovics Z, Rakvács M, Strausz J, Repa I (2013) First result of differentiated communication—to smokers and non-smokers—in order to increase the voluntary participation rate in lung screening. BMC Public Health 13:914PubMedCentralCrossRefPubMed Moizs M, Bajzik G, Lelovics Z, Rakvács M, Strausz J, Repa I (2013) First result of differentiated communication—to smokers and non-smokers—in order to increase the voluntary participation rate in lung screening. BMC Public Health 13:914PubMedCentralCrossRefPubMed
11.
go back to reference Moizs M, Bajzik G, Lelovics ZS, Rakvács M, Strausz J, Repa I (2014) Preliminary experiences of introducing low dose CT lung cancer screening in Hungary. Orv Hetil 155:383–388, In Hung CrossRefPubMed Moizs M, Bajzik G, Lelovics ZS, Rakvács M, Strausz J, Repa I (2014) Preliminary experiences of introducing low dose CT lung cancer screening in Hungary. Orv Hetil 155:383–388, In Hung CrossRefPubMed
12.
go back to reference Callol L, Roig F, Cuevas A, de Granda JI, Villegas F, Jareño J et al (2007) Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer 56:217–221CrossRefPubMed Callol L, Roig F, Cuevas A, de Granda JI, Villegas F, Jareño J et al (2007) Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer 56:217–221CrossRefPubMed
13.
go back to reference Menezes RJ, Roberts HC, Paul NS, McGregor M, Chung TB, Patsios D, Weisbrod G, Herman S, Pereira A, McGregor A, Dong Z, Sitartchouk I, Boerner S, Tsao MS, Keshavjee S, Shepherd FA (2010) Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 67:177–183CrossRefPubMed Menezes RJ, Roberts HC, Paul NS, McGregor M, Chung TB, Patsios D, Weisbrod G, Herman S, Pereira A, McGregor A, Dong Z, Sitartchouk I, Boerner S, Tsao MS, Keshavjee S, Shepherd FA (2010) Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 67:177–183CrossRefPubMed
14.
go back to reference US Centers for Disease Control and Prevention (2010). Health behaviors of adults: United States, 2005-2007. Vital and Health Statistics, Series 10, Number 245, Appendix II, p. 80 US Centers for Disease Control and Prevention (2010). Health behaviors of adults: United States, 2005-2007. Vital and Health Statistics, Series 10, Number 245, Appendix II, p. 80
15.
go back to reference National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF (2010) Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 102:1771–1779CrossRef National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF (2010) Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 102:1771–1779CrossRef
16.
go back to reference Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC (2012) Benefits and harms of CT screening for lung cancer. A systematic review. JAMA 307:2418–2429PubMedCentralCrossRefPubMed Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC (2012) Benefits and harms of CT screening for lung cancer. A systematic review. JAMA 307:2418–2429PubMedCentralCrossRefPubMed
17.
go back to reference NLST (2011) The national lung screening trial research team: reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409CrossRef NLST (2011) The national lung screening trial research team: reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409CrossRef
18.
go back to reference Wender R, Fontham ETH, Barrera E, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA (2013) American cancer society lung cancer screening guidelines. CA Cancer J Clin 63:107–117PubMedCentralCrossRefPubMed Wender R, Fontham ETH, Barrera E, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA (2013) American cancer society lung cancer screening guidelines. CA Cancer J Clin 63:107–117PubMedCentralCrossRefPubMed
19.
go back to reference Marshall HM, Bowman RV, Yang IA, Fong KM, Berg CD (2013) Screening for lung cancer with low-dose computed tomography: a review of current status. J Thorac Dis 5:S524–S539PubMedCentralPubMed Marshall HM, Bowman RV, Yang IA, Fong KM, Berg CD (2013) Screening for lung cancer with low-dose computed tomography: a review of current status. J Thorac Dis 5:S524–S539PubMedCentralPubMed
20.
go back to reference Tammemagi MC, Lam S (2014) Screening for lung cancer using low dose computed tomography. BMJ 348:g2253CrossRefPubMed Tammemagi MC, Lam S (2014) Screening for lung cancer using low dose computed tomography. BMJ 348:g2253CrossRefPubMed
Metadata
Title
Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program
Authors
Mariann Moizs
Gábor Bajzik
Zsuzsanna Lelovics
János Strausz
Marianna Rakvács
Péter Zádori
Árpád Kovács
Imre Repa
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 4/2015
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-015-9929-4

Other articles of this Issue 4/2015

Pathology & Oncology Research 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine